ClinicalTrials.Veeva

Menu

Local Anesthetic Automated Intermittent Administration vs. Continuous Infusion Via Femoral Nerve Block.

J

J P Lecoq

Status and phase

Completed
Phase 4

Conditions

Postoperative Complications
Postoperative Pain

Treatments

Drug: Ropivacaine Hcl 0.2% Inj Bag 200Ml (CI mode)
Drug: Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode)

Study type

Interventional

Funder types

Other

Identifiers

NCT03696095
2018-000822-70

Details and patient eligibility

About

This study evaluates the impact of local anesthetic administration regiment through peri-neural femoral nerve catheter on pain and motor block frequency, after total knee arthroplasty.

Full description

This study evaluates the impact of local anesthetic administration regiment through peri-neural femoral nerve catheter on pain and motor block frequency, after total knee arthroplasty. One group of patients will receive automated intermittent bolus, while the others will get a continuous infusion. In both cases, patients will be able to administer supplementary auto-bolus if required.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • admitted for unilateral primary total knee arthroplasty.

Exclusion criteria

  • ASA score > 3
  • BMI > 40
  • refusal of loco-regional technique.
  • psychiatric disease.
  • inability to understand/ use the Local anesthetic delivery pump.
  • local anesthetic allergy,
  • porphyry,
  • uncontrolled epilepsy,
  • severe cardiac arrhythmia.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

70 participants in 2 patient groups

Continous infusion ropivacaine
Active Comparator group
Description:
Continuous infusion via peri-neural femoral nerve catheter of Ropivacaine Hcl 0.2% Inj Bag 200Ml (CI mode) at rate of 6ml/h + patient controlled bolus of 3ml ...
Treatment:
Drug: Ropivacaine Hcl 0.2% Inj Bag 200Ml (CI mode)
PIB ropivacaine
Experimental group
Description:
Programmed intermittent bolus of Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode) : 6ml each 60min + patient controlled bolus 3ml ...
Treatment:
Drug: Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems